2 4 6 tris dimethylamino 1 3 5 triazine, 2 4 6 tris dimethylamino s triazine, altretamin
For use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating ...